-transparent.png){kind=logo}
Calyculin A and okadaic acid induce contraction in smooth muscle fibers. Okadaic acid is an inhibitor of phosphatase activity and the aims of this study were to determine if calyculin A also inhibits phosphatase and to screen effects of both compounds on various phosphatases. Neither compound inhibited acid or alkaline phosphatases, nor the phosphotyrosine protein phosphatase. Both compounds were potent inhibitors of the catalytic subunit of type-2A phosphatase, with IC50 values of 0.5 to 1 nM. With the catalytic subunit of protein phosphatase type-1, calyculin A was a more effective inhibitor than okadaic acid, IC50 values for calyculin A were about 2 nM and for okadaic acid between 60 and 500 nM. The endogenous phosphatase of smooth muscle myosin B was inhibited by both compounds with IC50 values of 0.3 to 0.7 nM and 15 to 70 nM, for calyculin A and okadaic acid, respectively. The partially purified catalytic subunit from myosin B had IC50 values of 0.7 and 200 nM for calyculin A and okadaic acid, respectively. The pattern of inhibition for the phosphatase in myosin B therefore is similar to that of the type-1 enzyme.
H Ishihara, and
B L Martin, and
D L Brautigan, and
H Karaki, and
H Ozaki, and
Y Kato, and
N Fusetani, and
S Watabe, and
K Hashimoto, and
D Uemura
June 1995,
Biochemistry and molecular biology international,
H Ishihara, and
B L Martin, and
D L Brautigan, and
H Karaki, and
H Ozaki, and
Y Kato, and
N Fusetani, and
S Watabe, and
K Hashimoto, and
D Uemura
February 1997,
Experimental cell research,
H Ishihara, and
B L Martin, and
D L Brautigan, and
H Karaki, and
H Ozaki, and
Y Kato, and
N Fusetani, and
S Watabe, and
K Hashimoto, and
D Uemura
June 1992,
Endocrinology,
H Ishihara, and
B L Martin, and
D L Brautigan, and
H Karaki, and
H Ozaki, and
Y Kato, and
N Fusetani, and
S Watabe, and
K Hashimoto, and
D Uemura
October 1995,
Cell death and differentiation,
H Ishihara, and
B L Martin, and
D L Brautigan, and
H Karaki, and
H Ozaki, and
Y Kato, and
N Fusetani, and
S Watabe, and
K Hashimoto, and
D Uemura
October 1993,
FEBS letters,
H Ishihara, and
B L Martin, and
D L Brautigan, and
H Karaki, and
H Ozaki, and
Y Kato, and
N Fusetani, and
S Watabe, and
K Hashimoto, and
D Uemura
January 1992,
Biochemistry and cell biology = Biochimie et biologie cellulaire,
H Ishihara, and
B L Martin, and
D L Brautigan, and
H Karaki, and
H Ozaki, and
Y Kato, and
N Fusetani, and
S Watabe, and
K Hashimoto, and
D Uemura
August 1992,
Journal of molecular and cellular cardiology,
H Ishihara, and
B L Martin, and
D L Brautigan, and
H Karaki, and
H Ozaki, and
Y Kato, and
N Fusetani, and
S Watabe, and
K Hashimoto, and
D Uemura
May 1997,
Biochemical Society transactions,
H Ishihara, and
B L Martin, and
D L Brautigan, and
H Karaki, and
H Ozaki, and
Y Kato, and
N Fusetani, and
S Watabe, and
K Hashimoto, and
D Uemura
June 1992,
Endocrinologia japonica,
H Ishihara, and
B L Martin, and
D L Brautigan, and
H Karaki, and
H Ozaki, and
Y Kato, and
N Fusetani, and
S Watabe, and
K Hashimoto, and
D Uemura
April 1995,
The Biochemical journal,
